scholarly journals The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

2019 ◽  
Vol 4 (6) ◽  
pp. 435-444 ◽  
Author(s):  
Adam Trickey ◽  
Hannah Fraser ◽  
Aaron G Lim ◽  
Amy Peacock ◽  
Samantha Colledge ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Use ◽  
Injection Drug Use ◽  
Virus Transmission ◽  
Injection Drug ◽  
Country Level ◽  
Modelling Study ◽  
Hepatitis C Virus Transmission

Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history

AIDS ◽  
2014 ◽  
Vol 28 (1) ◽  
pp. 121-127 ◽  
Author(s):  
Angela Cescon ◽  
Keith Chan ◽  
Janet M. Raboud ◽  
Ann N. Burchell ◽  
Jamie I. Forrest ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Use ◽  
Clinical Outcomes ◽  
Injection Drug Use ◽  
Injection Drug

scholarly journals Predictors of Active Injection Drug Use in a Cohort of Patients Infected With Hepatitis C Virus

2013 ◽  
Vol 103 (1) ◽  
pp. 105-111 ◽  
Author(s):  
Carrie Reed ◽  
Caleb Bliss ◽  
Sherri O. Stuver ◽  
Timothy Heeren ◽  
Sheila Tumilty ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Use ◽  
Injection Drug Use ◽  
Injection Drug

scholarly journals Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam

2010 ◽  
Vol 82 (8) ◽  
pp. 1355-1363 ◽  
Author(s):  
Tomoaki Tanimoto ◽  
Nguyen Hung Cuong ◽  
Azumi Ishizaki ◽  
Phan Thi Thu Chung ◽  
Hoang Thi Thanh Huyen ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Injection Drug Users ◽  
Drug Users ◽  
Virus Transmission ◽  
Injection Drug ◽  
Northern Vietnam ◽  
Multiple Routes ◽  
Hepatitis C Virus Transmission

scholarly journals Distribution of Hepatitis C Virus Genotypes in Canada: Results from the LCDC Sentinel Health Unit Surveillance System

1999 ◽  
Vol 10 (1) ◽  
pp. 53-56 ◽  
Author(s):  
RK Chaudhary ◽  
M Tepper ◽  
S Eisaadany ◽  
Paul R Gully
Keyword(s):  
Risk Factor ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Use ◽  
Injection Drug Use ◽  
Injection Drug Users ◽  
Drug Users ◽  
Injection Drug ◽  
Major Risk Factor ◽  
Hcv Rna

In a sentinel hepatitis surveillance study conducted by sentinel health units, 1469 patients were enrolled, and 959 (65.3%) were positive for antibody to hepatitis C virus (HCV). Samples from 387 patients (40.4%) were tested for HCV RNA, and 289 (74.7%) were positive for RNA. The major risk factor for HCV infection was injection drug use, reported in 71% of cases. The genotyping of HCV isolates showed that subtype 1a (48%) was predominant in Canada. The other subtypes detected were 1b (19%), 2a (6%), 2b (3%), 3a (22%) and 4a (1%). In Winnipeg, Manitoba, subtype 3a (47%) was more prevalent than subtype 1a (37%), and, in Guelph, Ontario, both subtypes 1a and 3a had equal (40%) distribution. The prevalence of subtype 3a was significantly higher in injection drug users (27%) than in nonusers (10%) (P<0.005). In Canada, injection drug use is the major risk factor for HCV infections, and subtype 1a is more prevalent.

Sign in / Sign up

Export Citation Format

Share Document